DMAC Competitors & Alternatives
Compare DiaMedica Therapeutics Inc with similar stocks in the same industry
Biotechnology
DMAC
Main Stock$7.62
Tradestie Score
54
Market Cap
$354.59M
Analyst Upside
+103.4%
Top Competitors
236 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DRUG
Bright Minds Biosciences Inc. Common Stock
|
$67.60
|
$410.79M | - | 52 | Compare |
|
FDMT
4D Molecular Therapeutics, Inc. Common Stock
|
$13.00
|
$407.71M | - | 64 | Compare |
|
DSGN
Design Therapeutics, Inc. Common Stock
|
$15.64
|
$386.68M | - | 58 | Compare |
|
AURA
Aura Biosciences, Inc. Common Stock
|
$7.74
|
$382.04M | - | 53 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$13.23
|
$371.64M | - | 61 | Compare |
|
CAPR
Capricor Therapeutics Inc
|
$23.21
|
$357.51M | - | 54 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$17.63
|
$354.45M | - | 60 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$33.43
|
$353.70M | - | 60 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$2.03
|
$350.98M | - | 57 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$3.16
|
$341.56M | - | 59 | Compare |
More DMAC Analysis
Data updated: Jul 05, 2026 | Industry: Biotechnology (SIC 2834)
236 stocks in this industry